Update on infectious complications following lung transplantation
- 1 May 2011
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in Current Opinion in Pulmonary Medicine
- Vol. 17 (3), 206-209
- https://doi.org/10.1097/mcp.0b013e328344dba5
Abstract
Lung transplantation is an important therapeutic treatment for many patients with life-threatening pulmonary diseases; however, long-term survival is still relatively limited compared with other solid organ transplants. Over the last year, several articles have been published helping to increase our knowledge of infections in lung transplant recipients. In particular, important new information has been published recently regarding cytomegalovirus (CMV) and fungal infections following lung transplantation. Recent studies indicate prolonged (≥12 months) antiviral prophylaxis for CMV after lung transplant may be beneficial in high-risk transplant recipients. Epidemiologic studies show invasive fungal infections are increasingly being recognized following solid organ transplantation, particularly with Aspergillus and Candida species. Pulmonary infections with CMV and Aspergillus are likely contributors to the development of bronchiolitis obliterans syndrome (BOS). Lung transplantation has many potential posttransplant complications with infection being a major contributor. More information has become available regarding CMV prophylaxis, CMV treatment, pulmonary fungal infection epidemiology, and the role of both CMV and Aspergillus on the development of BOS, which helps toward the goal of increasing long-term survival in lung transplant recipients.Keywords
This publication has 13 references indexed in Scilit:
- The Registry of the International Society for Heart and Lung Transplantation: Twenty-seventh official adult lung and heart-lung transplant report—2010The Journal of Heart and Lung Transplantation, 2010
- An International Survey of Cytomegalovirus Management Practices in Lung TransplantationTransplantation, 2010
- Utility of Leflunomide in the Treatment of Complex Cytomegalovirus SyndromesTransplantation, 2010
- Virologic Characterization of Multidrug‐Resistant Cytomegalovirus Infection in 2 Transplant Recipients Treated with MaribavirThe Journal of Infectious Diseases, 2010
- Cytomegalovirus Pneumonitis Is a Risk for Bronchiolitis Obliterans Syndrome in Lung TransplantationAmerican Journal of Respiratory and Critical Care Medicine, 2010
- Extended Valganciclovir Prophylaxis to Prevent Cytomegalovirus After Lung TransplantationAnnals of Internal Medicine, 2010
- Invasive Fungal Infections among Organ Transplant Recipients: Results of the Transplant‐Associated Infection Surveillance Network (TRANSNET)Clinical Infectious Diseases, 2010
- Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus GroupClinical Infectious Diseases, 2008
- Fungal infections in the recipients of solid organ transplantationInfectious Disease Clinics of North America, 2003
- Infectious complications of lung transplantationTransplant Infectious Disease, 2001